Feliza Mirasol is the science editor for 

Videos

CPHI Milan 2024: Industry Trends Impacting Oral Solid Dose Formulation

Pharmaceutical Technology® Europe sat down with Vinod Tuliani, Head of Pharmaceutical Sciences at Roquette, to talk about new developments in the use of excipients in dosage forms and methods of delivery. 

CPHI Milan 2024: The Role of Excipients in Pharmaceuticals

Articles

The winners of this year’s awards showcase achievements in pharma excellence.

Winners of CPHI Excellence in Pharma Awards Announced

Patrick Lavery is an Editor for the MJH Life Sciences brands 

. Previously at MJH, he filled the same role for 

European biotechs have had a strong year in 2024, causing those in the United States to increasingly look to them for innovation.

CPHI Research Forecasts Growth for Biotech, Pharma Markets in 2025

Felicity Thomas is the former Associate Editorial Director of Pharmaceutical Technology, Pharmaceutical Technology Europe, BioPharm International.

James Hamilton, president of Sharp Sterile, discussed innovation in products associated with sterile manufacturing and industry trends that are driving growth.

CPHI Milan 2024: Growth and Challenges in the Sterile Injectables Market

According to the annual survey, four of the five biggest biologics capacity holders in 2028 will comprise CMOs, which are expected to have 45% of all CMO capacity in Asia.

CMOs and Hybrid Companies Predicted to Hold 54% of Biologics Capacity in 2028, According to CPHI Annual Survey

The company has expanded its NeoFlex coated plungers with new sizes for large-volume auto-injectors and wearable devices. 

Datwyler Launches NeoFlex Plungers at CPHI Milan 2024

The introduction of Accelerator Drug Development follows expansions of sites in Cincinnati, Ohio, and Bend, Ore., earlier in 2024 to enable R&D, manufacturing, and testing.

Thermo Fisher Launching New CDMO, CRO Services at CPHI Milan

Pharmaceutical Technology® Europe sat down with Álvaro Nocete Díaz, Pharma Division Manager at HTBA, about the benefits of flavonoids and their use in the pharmaceutical industry. 

CPHI Milan 2024: Flavonoids in Pharmaceuticals

Andrew Lewis, PhD, Chief Scientific Officer, Quotient Sciences, discussed the CMC challenges with GLP-1 and oral peptides during CPHI Milan.

News